BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21278615)

  • 1. Impact of 123I-FP-CIT (DaTSCAN) SPECT on the diagnosis and management of patients with dementia with Lewy bodies: a retrospective study.
    Kemp PM; Clyde K; Holmes C
    Nucl Med Commun; 2011 Apr; 32(4):298-302. PubMed ID: 21278615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study.
    Tiraboschi P; Corso A; Guerra UP; Nobili F; Piccardo A; Calcagni ML; Volterrani D; Cecchin D; Tettamanti M; Antelmi L; Vidale S; Sacco L; Merello M; Stefanini S; Micheli A; Vai P; Capitanio S; Gabanelli SV; Riva R; Pinto P; Biffi AM; Muscio C;
    Ann Neurol; 2016 Sep; 80(3):368-78. PubMed ID: 27398636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy.
    Walker Z; Jaros E; Walker RW; Lee L; Costa DC; Livingston G; Ince PG; Perry R; McKeith I; Katona CL
    J Neurol Neurosurg Psychiatry; 2007 Nov; 78(11):1176-81. PubMed ID: 17353255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 123I-FP-CIT SPECT in the differential diagnosis between dementia with Lewy bodies and other dementias.
    Brigo F; Turri G; Tinazzi M
    J Neurol Sci; 2015 Dec; 359(1-2):161-71. PubMed ID: 26671107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study.
    McKeith I; O'Brien J; Walker Z; Tatsch K; Booij J; Darcourt J; Padovani A; Giubbini R; Bonuccelli U; Volterrani D; Holmes C; Kemp P; Tabet N; Meyer I; Reininger C;
    Lancet Neurol; 2007 Apr; 6(4):305-13. PubMed ID: 17362834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [(123)]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies.
    van der Zande JJ; Booij J; Scheltens P; Raijmakers PG; Lemstra AW
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1060-6. PubMed ID: 26830298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT.
    Morgan S; Kemp P; Booij J; Costa DC; Padayachee S; Lee L; Barber C; Carter J; Walker Z
    J Neurol Neurosurg Psychiatry; 2012 Nov; 83(11):1063-70. PubMed ID: 22869921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies.
    Colloby SJ; Firbank MJ; Pakrasi S; Lloyd JJ; Driver I; McKeith IG; Williams ED; O'Brien JT
    Int Psychogeriatr; 2008 Dec; 20(6):1124-40. PubMed ID: 18752700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitations of the HMPAO SPECT appearances of occipital lobe perfusion in the differential diagnosis of dementia with Lewy bodies.
    Kemp PM; Hoffmann SA; Tossici-Bolt L; Fleming JS; Holmes C
    Nucl Med Commun; 2007 Jun; 28(6):451-6. PubMed ID: 17460535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confirmation of
    Maltais DD; Jordan LG; Min HK; Miyagawa T; Przybelski SA; Lesnick TG; Reichard RR; Dickson DW; Murray ME; Kantarci K; Boeve BF; Lowe VJ
    J Nucl Med; 2020 Nov; 61(11):1628-1635. PubMed ID: 32198310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic performance of functional dopaminergic scintigraphic imaging in the diagnosis of dementia with Lewy bodies: an updated systematic review.
    Jreige M; Kurian GK; Perriraz J; Potheegadoo J; Bernasconi F; Stampacchia S; Blanke O; Alessandra G; Lejay N; Chiabotti PS; Rouaud O; Nicod Lalonde M; Schaefer N; Treglia G; Allali G; Prior JO
    Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):1988-2035. PubMed ID: 36920494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The applicability of 123I-FP-CIT SPECT dopamine transporter imaging in clinical practice].
    Perlaki G; Szekeres S; Janszky J; Dezső D; Aschermann Z; Zámbó K; Kovács N
    Ideggyogy Sz; 2019 Nov; 72(11-12):381-388. PubMed ID: 31834681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of ¹²³I-FP-CIT (DaTSCAN) in dementia with Lewy bodies: a meta-analysis of published studies.
    Papathanasiou ND; Boutsiadis A; Dickson J; Bomanji JB
    Parkinsonism Relat Disord; 2012 Mar; 18(3):225-9. PubMed ID: 21975260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB.
    Thomas AJ; Attems J; Colloby SJ; O'Brien JT; McKeith I; Walker R; Lee L; Burn D; Lett DJ; Walker Z
    Neurology; 2017 Jan; 88(3):276-283. PubMed ID: 27940650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [123I]N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)nortropane single-photon emission computed tomography brain imaging in the diagnosis of dementia with Lewy bodies.
    Walker Z; Cummings JL
    Alzheimers Dement; 2012 Jan; 8(1):74-83. PubMed ID: 22024052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.
    O'Brien JT; Colloby S; Fenwick J; Williams ED; Firbank M; Burn D; Aarsland D; McKeith IG
    Arch Neurol; 2004 Jun; 61(6):919-25. PubMed ID: 15210531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Sensitivity and Symptomatic Relevance of Dopamine Transporter Imaging and Myocardial Sympathetic Scintigraphy in Patients with Dementia with Lewy Bodies.
    Tang Z; Hirano S; Koizumi Y; Izumi M; Kitayama Y; Yamagishi K; Tamura M; Ishikawa A; Kashiwado K; Iimori T; Mukai H; Yokota H; Horikoshi T; Uno T; Kuwabara S
    J Alzheimers Dis; 2024; 100(1):127-137. PubMed ID: 38848178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand.
    Walker Z; Costa DC; Walker RW; Shaw K; Gacinovic S; Stevens T; Livingston G; Ince P; McKeith IG; Katona CL
    J Neurol Neurosurg Psychiatry; 2002 Aug; 73(2):134-40. PubMed ID: 12122169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of semiquantitative assessment of regional binding potential in 123I-FP-CIT SPECT for the differentiation of frontotemporal dementia, dementia with Lewy bodies, and Alzheimer's dementia.
    Spehl TS; Frings L; Hellwig S; Weiller C; Hüll M; Meyer PT; Amtage F
    Clin Nucl Med; 2015 Jan; 40(1):e27-33. PubMed ID: 25140560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac sympathetic impairment parallels nigrostriatal degeneration in Probable Dementia with Lewy Bodies.
    Camacho V; Marquié M; Lleó A; Alvés L; Artigas C; Flotats A; Duch J; Blesa R; Gómez-Isla T; Carrió I; Estorch M
    Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):476-83. PubMed ID: 21150861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.